Lupifil-P | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

The most frequently reported adverse reactions with pegfilgrastim are bone pain (very common [≥1/:10]) and musculoskeletal pain (very common [≥1/10]). Bone pain is generally of mild to moderate severity, transient and can be controlled in most patients with standard analgesics.
Hypersensitivity-type reactions, including skin rash, urticaria, angioedema, dyspnoea, erythema, flushing, and hypotension can occur on initial or subsequent treatment with pegfilgrastim (uncommon [≥1/1,000 to <1/100]). Serious allergic reactions, including anaphylaxis can occur in patients receiving pegfilgrastim (uncommon [≥1/1,000 to <1/100]).
Splenomegaly, generally asymptomatic, is uncommon [≥1/1,000 to <1/100). Splenic rupture including some fatal cases is uncommonly [≥1/1,000 to <1/100) reported following administration of pegfilgrastim.
Following table summarizes the data of adverse reactions reported with pegfilgrastim. (See table.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Lupifil-P Adverse Reactions

pegfilgrastim

Manufacturer:

Lupin Limited

Distributor:

Atlanta Medicare

Marketer:

Atlanta Medicare